Pharmala Biotech Holdings Inc. (CSE:MDMA)

Pharmala Biotech Holdings Statistics

Total Valuation

CSE:MDMA has a market cap or net worth of CAD 15.24 million. The enterprise value is 14.67 million.

Market Cap	15.24M
Enterprise Value	14.67M

Important Dates

The next estimated earnings date is Wednesday, May 6, 2026.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

CSE:MDMA has 108.89 million shares outstanding. The number of shares has increased by 12.44% in one year.

Current Share Class	108.89M
Shares Outstanding	108.89M
Shares Change (YoY)	+12.44%
Shares Change (QoQ)	+0.81%
Owned by Insiders (%)	8.35%
Owned by Institutions (%)	n/a
Float	99.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.14
PB Ratio	7.07
P/TBV Ratio	36.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.98
EV / Sales	16.49
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-15.92

Financial Position

The company has a current ratio of 1.42

Current Ratio	1.42
Quick Ratio	1.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -62.20% and return on invested capital (ROIC) is -34.22%.

Return on Equity (ROE)	-62.20%
Return on Assets (ROA)	-25.53%
Return on Invested Capital (ROIC)	-34.22%
Return on Capital Employed (ROCE)	-66.65%
Weighted Average Cost of Capital (WACC)	8.12%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.25
Inventory Turnover	0.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.15% in the last 52 weeks. The beta is 0.70, so CSE:MDMA's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	-15.15%
50-Day Moving Average	0.11
200-Day Moving Average	0.11
Relative Strength Index (RSI)	54.75
Average Volume (20 Days)	399,189

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:MDMA had revenue of CAD 889,568 and -1.63 million in losses. Loss per share was -0.02.

Revenue	889,568
Gross Profit	788,664
Operating Income	-1.44M
Pretax Income	-1.63M
Net Income	-1.63M
EBITDA	-1.42M
EBIT	-1.44M
Loss Per Share	-0.02

Balance Sheet

The company has 577,564 in cash and n/a in debt, with a net cash position of 577,564 or 0.01 per share.

Cash & Cash Equivalents	577,564
Total Debt	n/a
Net Cash	577,564
Net Cash Per Share	0.01
Equity (Book Value)	2.16M
Book Value Per Share	0.02
Working Capital	411,732

Cash Flow

In the last 12 months, operating cash flow was -918,372 and capital expenditures -2,918, giving a free cash flow of -921,290.

Operating Cash Flow	-918,372
Capital Expenditures	-2,918
Depreciation & Amortization	21,559
Net Borrowing	n/a
Free Cash Flow	-921,290
FCF Per Share	-0.01

Margins

Gross margin is 88.66%, with operating and profit margins of -161.56% and -183.55%.

Gross Margin	88.66%
Operating Margin	-161.56%
Pretax Margin	-183.55%
Profit Margin	-183.55%
EBITDA Margin	-159.13%
EBIT Margin	-161.56%
FCF Margin	n/a

Dividends & Yields

CSE:MDMA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.44%
Shareholder Yield	-12.44%
Earnings Yield	-10.71%
FCF Yield	-6.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CSE:MDMA has an Altman Z-Score of 3.42 and a Piotroski F-Score of 2.

Altman Z-Score	3.42
Piotroski F-Score	2